Anjarium Biosciences (private company)
See something wrong or missing? Let us know
Offices:Schlieren
Industry:BiotechHealth servicesPharma
Business model:B2B
Anjarium uses science and expertise at the interface of genetic medicine, synthetic biology and nanoparticle engineering to rationally design and produce tissue-targeted gene therapies for a range of serious genetic diseases.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 59.53M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Anjarium Biosciences
Name | Criteria | |
---|---|---|
![]() |
STipe Therapeutics
67%
|
|
![]() |
PetMedix
67%
|
|
![]() |
Cytoki Pharma
67%
|
|
![]() |
Cardior Pharmaceuticals
67%
|
|
![]() |
Sanifit Therapeutics
67%
|
|
![]() |
Causaly
67%
|
|
![]() |
NMD Pharma
67%
|
|
![]() |
ReViral
67%
|
|
![]() |
Exiscientia
63%
|
|
![]() |
Cinclus Pharma
63%
|
|